Cargando…
Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist
Background: Roflumilast is an option for treating patients with severe COPD and frequent exacerbations despite optimal therapy with inhaled drugs. The present study focused on whether the phosphodiesterase (PDE) 4 inhibitor roflumilast and its active metabolite roflumilast N-oxide affect the release...
Autores principales: | Salvator, Hélène, Buenestado, Amparo, Brollo, Marion, Naline, Emmanuel, Victoni, Tatiana, Longchamp, Elisabeth, Tenor, Hermann, Grassin-Delyle, Stanislas, Devillier, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754640/ https://www.ncbi.nlm.nih.gov/pubmed/33363471 http://dx.doi.org/10.3389/fphar.2020.598702 |
Ejemplares similares
-
Roflumilast Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α and Chemokine Production by Human Lung Parenchyma
por: Buenestado, Amparo, et al.
Publicado: (2013) -
Human lung and monocyte-derived macrophages differ with regard to the effects of β(2)-adrenoceptor agonists on cytokine release
por: Victoni, Tatiana, et al.
Publicado: (2017) -
Adiponectin Inhibits the Production of TNF-α, IL-6 and Chemokines by Human Lung Macrophages
por: Salvator, Hélène, et al.
Publicado: (2021) -
Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists
por: Grassin-Delyle, Stanislas, et al.
Publicado: (2019) -
Contrasting Effects of Adipokines on the Cytokine Production by Primary Human Bronchial Epithelial Cells: Inhibitory Effects of Adiponectin
por: Salvator, Hélène, et al.
Publicado: (2020)